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Abstract
sPLA2 from Crotalus durissus terrificus venom, free of crotapotin (Cdt sPLA2), 
purified and isolated sPLA2, was able to significantly increase lipid peroxida-
tion, which occurred simultaneously with increased arachidonic acid (AA) 
metabolism. In addition, MDA and AA levels were elevated at 15 min after Cdt 
sPLA2 injection and after peak edema (negative control). Thus, oxidative stress 
and ROS play important roles in the inflammation induced by Cdt sPLA2. On 
the other hand, edema induced by sPLA2 involves the direct and indirect mobi-
lization of arachidonic acid by the involvement of phosphokinase C (PKC) and 
phospholipase C (PLC), which indirectly stimulates cytosolic PLA2 (cPLA2). We 
also observed that the specific antivenin against Cdt venom had no significant 
effect on the neutralization of induced edema compared to the natural products 
5-caffeine-linoleic acid (5CQA) and dexamethasone (AACOCF3). Our results 
also indicate that there was improvement in the inhibition of edema of natural 
polyphenolic compounds compared to antivenin or inhibition of the enzymatic 
activity of sPLA2 due to the fact that 5CQA is a potent antioxidant compound.  
Thus, our results show a clear correlation between increased arachidonic acid 
metabolism and oxidative stress.
Keywords: Crotalus durissus terrificus (Cdt), secretory snake venom phospholipase 
A2, edema, PKC, PLC, inflammation, oxidative stress
1. Arachidonic acid “dogma”
Arachidonic acid (ARA) is a 20-carbon chain fatty acid with four methylene-
interrupted cis double bonds; the first, with respect to the methyl end (omega, ω 
or n), is located between carbons 6 and 7. Arachidonic acid (AA) has three possible 
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Figure 1. 
Central dogma of arachidonic acid metabolism. AA cascade and its destination following three major oxidative 
pathways: (1) cyclooxygenase (COX), producing prostaglandins and related eicosanoids; (2) lipoxygenase 
(LOX), forming leukotrienes and related compounds; and (3) CYP450, forming arachidonic acid epoxides.
destinations: participating in the remodeling process of the cell membrane, release 
into the extracellular medium by diffusion, or its intracellular metabolism [1, 2]. In 
addition to AA, lysophosphatidic acid (lyso-platelet aggregation factor (PAF)) is 
another product of the enzymatic hydrolysis of membrane phospholipids, which, in 
the presence of lyso-PAF acyl transferase, is converted in PAF [3]. PAF is an extra-
cellular lipid signaling molecule involved in a range of cellular activities, including 
survival, differentiation, cellular proliferation, morphological changes, and migra-
tion, among others [4]. Besides, its biological action is mediated by the presence 
of a cellular receptor (PAF-receptor (PAF-R)) (Figure 1). These physiological and 
pharmacological activities of PAF depend on the presence of its receptors, desig-
nated as PAF-R1 to PAF-R6. These receptors are G protein-coupled transmembrane 
receptors, and recent studies revealed that the PAF-R signaling pathway clearly 
affects different aspects of tumor progression [5, 6]. In the literature, it is well 
established that phospholipases A2 (PLA2s) are key enzymes involved in AA gen-
eration by hydrolytic digestion of membrane phospholipids. PLA2 is a superfamily 
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of enzymes distributed throughout six major classes: secretory PLA2 (sPLA2), 
calcium-dependent cytosolic PLA2 (cPLA2), calcium-independent cytosolic PLA2 
(iPLA2), lysosomal PLA2 (lPLA2), mitochondrial PLA2 (mPLA2), and, more 
recently, PAF-acetyl hydrolases (PAF-AHs). PAF-AHs are a small family of phos-
pholipases A2 with a high specificity for the hydrolysis of the unsaturated fatty acid 
residue located at the sn-2 position [7, 8]. sPLA2 is considered a simple and primi-
tive enzyme, acting as an inducer of the inflammatory process, besides being able to 
act as a pseudohormone. In addition to generating AA directly, this enzyme can also 
increase the activity of cPLA2 [9]. Furthermore, the produced AA usually follows 
one of three distinct enzymatic pathways involving cyclooxygenase, lipoxygenase, 
and cytochrome P450. Several products of these routes can modulate the func-
tions of ion channels, protein kinases, and ion pumps. In addition, newly formed 
eicosanoids are excreted and mediate various physiological functions, including 
insulin secretion and muscle contraction, and most of these actions involve protein 
G. Ultimately, the products of AA metabolism are rapidly degraded [1, 10]. Briefly, 
AA, as well as other polyunsaturated fatty acids (PUFAs) generated at the cellular 
level, can be mobilized through the hydrolytic activity of various enzymes. It is 
possible to highlight the action of PLA2 through a single reaction pathway that pro-
duces AA and lysophospholipid (LysP), which is considered the classical pathway 
of AA generation—it is the most widely known and studied. In addition, AA is 
metabolized by cyclooxygenase (COX) and 5-lipoxygenase, resulting in the synthe-
sis of prostaglandins and leukotrienes, respectively. These intracellular messengers 
play an important role in the regulation of signal transduction, leading to pain and 
inflammatory responses. Recently, the literature has shown that AA can follow a 
third pathway, resulting in its metabolism by cytochrome P450 enzymes—Cyt450 
epoxygenase and Cyt450 omega hydroxylase. P450s are typical monooxygenases, 
which enzymatically cleave molecular oxygen, followed by the insertion of a single 
atom of oxygen into the substrate, while the remainder is released as water [11–14]. 
Cytochrome P450s metabolize AA to produce the collectively designated hydroxye-
icosatetraenoic acids and epoxyeicosatrienoic acids; these bioactive compounds are 
generated in a tissue- and cell-specific manner, and numerous biological functions 
have been revealed (Figure 1).
2. Secretory phospholipase A2
Phospholipase A2 (EC 3.1.1.4, PLA2) belongs to the group of enzymes, which 
catalyze the hydrolysis of the ester bond at the sn-2 position of glycerophospho-
lipids and, consequently, are capable of generating free fatty acids, including 
arachidonic acid (AA). Under physiological conditions, PLA2s are crucial for 
membrane phospholipid homeostasis, ensuring membrane stability, fluidity, and 
permeability, and they are involved in the regulation of transport processes through 
the cell membrane. Phospholipases A2 are enzymes widely diffused in bacteria, 
plants, venom (of various animals), and mammal cells. Several studies suggest 
that these enzymes can be classified into 19 groups, which have been identi-
fied in mammalian tissues. Besides, many of these groups exhibit significant A2 
phospholipase enzymatic activity. At a high level, PLA2s can be classified into two 
groups: cytosolic PLA2 (cPLA2), and a large and diverse group of secretory PLA2s 
(sPLA2). Cytosolic PLA2 comprises calcium-dependent cPLA2 (cPLA2), calcium-
independent cytosolic PLA2 (iPLA2), lysosomal PLA2 (lPLA2), mitochondrial 
PLA2 (mPLA2), and, more recently, PAF-acetyl hydrolases (PAF-AHs), which 
display a small family of phospholipases A2 with high specificity for hydrolysis of 
the unsaturated fatty acid residue located at the sn-2 position [7, 8, 10]. Several 
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studies suggest that the proinflammatory action induced by mammalian sPLA2 and 
even snake venom sPLA2 involve a significant increase of both oxidative activity 
and reactive oxygen species (ROS) in the cell. ROS are involved in processes such 
as lipid peroxidation and protein carbonylation, which, at certain levels, can lead 
to pathological events [15]. Studies conducted by Chiricozzi et al. (2010) [16] 
reveal that there is a relationship between the increased enzymatic activity of 
sPLA2, which belongs to the IIA family, and a significant cellular production of 
free radicals, which contribute strongly to the development of neurodegenerative 
diseases. Snake venom sPLA2 shares similar mechanisms of action and the same 
pathways of action with mammalian sPLA2. Experimental evidence in the literature 
demonstrates that both sPLA2 isoforms are able to induce inflammation and other 
similar biological activities [10, 17–19]. It is noteworthy that literature data dem-
onstrate sPLA2 can activate signaling events that cannot be explained simply by 
its catalytic activity, and this fact emphasizes that sPLA2 could act essentially as a 
ligand of a receptor, rather than as an enzyme [20]. In contrast, studies suggest that 
products generated by sPLA2 may act as second intracellular messengers, and its 
enzymatic activity provides a crucial point in the biosynthesis pathways of several 
classes of inflammatory mediators [21]. In addition, studies performed with other 
sPLA2s suggest that, during the inflammatory process, leukocytes are recruited 
to the damaged site (via chemotaxis), where there are conditions necessary to 
produce a “respiratory explosion.” This condition is characterized by high oxygen 
consumption and the production of reactive oxygen species (ROS), such as the 
superoxide anion radical (O2
−•) and hydrogen peroxide (H2O2), which can generate 
the hydroxyl radical (•OH) directly or indirectly through chemical reactions, such 
as Fenton and Harber Weiss [22].
Nucleic acids, proteins, and lipids are important targets of ROS, and their attack 
may lead to an increased risk of mutagenesis due to the modification of these 
molecules. Moreover, during the inflammatory process, they synthesize soluble 
mediators, such as arachidonic acid metabolites, cytokines, and chemokines, which 
lead to the recruitment of more cells that are involved in the inflammatory process 
to the injured site, thus increasing ROS production. These key mediators may 
activate signal transduction cascades and induce changes in transcription factors, 
such as nuclear transcription factor κ-β (NFκ-β) and signal transducer/transcrip-
tional activator 3 (STAT 3), which mediate the response to cellular stress. In addi-
tion, induction of cyclooxygenase-2 (COX2) was reported to contribute to nitric 
oxide synthesis by the enzyme inducible nitric oxide synthetase (iNOS), besides the 
increased expression of tumor necrosis factor (TNF-α), interleukin-1 (IL-1), inter-
leukin-6 (IL-6), and alterations in the expression of specific microRNAs [23, 24]. It 
should be noted that nitric oxide can form reactive nitrogen species (RNS) that are 
highly damaging to cells [25, 26]. Signaling of inflammation is recognized globally 
by IL-1, IL-6, and TNF-α through Toll-like receptors (TLRs), which belong to the 
IL-1R family. IL-1 and TNF-α represent the proinflammatory cytokine archetypes 
that are readily released in response to tissue injury or infection, and they represent 
a programmed recognition system to trigger inflammation [27–29]. It is important 
to note that although nitric oxide (NO−•), generated by iNOS, has been revealed to 
have an essential role as a cellular marker, in an environment with oxidative stress, 
it can react with O2
−• to generate peroxynitrite (NOO−) and other harmful RNS 
species [26, 30]. Some authors suggest that preventing the formation of NOO- or 
inducing its efficient decomposition in inflammatory processes may result in a 
new therapeutic strategy for the treatment of inflammatory processes [30]. In this 
context, enzymes such as glutathione peroxidase (Gpx) and peroxiredoxin (Prx) 
appear to have great importance, since they respond to NOO− decomposition with 
high efficiency [30–33].
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3.  Edema induced by sPLA2 from Crotalus durissus terrificus involves 
oxidative stress signaling
There is no significant evidence that enzymatic toxins from snake venom are 
able to increase cellular oxidative stress during inflammation [34]; there has been 
neither a molecular nor a physiological connection shown between edema and other 
pharmacological activities induced by secretory phospholipase A2 from Crotalus 
Figure 2. 
Edema values induced by Cdt sPLA2 at the adjusted concentration of 10 μg/site (n = 5). Blood and tissue 
samples were collected from the animals in two phases: at 30 min (B–D) and 90 min (E–F). Measurements of 
COX2, PGE2, and MDA levels are representative of the analysis of five animals.
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durissus terrificus (Cdt sPLA2). However, our results show there is a biochemical, 
physiological, and temporal connection between the AA metabolism induced by 
sPLA2, culminating in edema, and the increase of cellular oxidative stress, which 
was evaluated by measuring malondialdehyde (MDA) content. MDA is a highly 
reactive three-carbon dialdehyde produced as a byproduct of polyunsaturated fatty 
acid peroxidation and AA metabolism. This compound produced by oxidative stress 
can interact with several molecules, including proteins, lipoproteins, and DNA. The 
main source of MDA in biological samples is the peroxidation of polyunsaturated 
fatty acids with two or more methylene-interrupted double bonds [35, 36]. H2O2 rep-
resents a messenger capable of altering redox homeostasis, contributing, at various 
levels, to related inflammatory diseases. Although H2O2 is not an inherently reactive 
compound, it can be converted into highly reactive and deleterious products that kill 
cells. In this context, several studies have shown that plant phenolic compounds have 
great neutralization capacity toward hydrogen peroxide, because these compounds 
can donate electrons to hydrogen peroxide and neutralize it as water [37, 38].
The edema values plotted in Figure 2A were obtained by subtracting the edema 
values induced by saline (negative control). In this work, we evaluated the activity 
of COX2 and quantified PEG2 and MDA in blood and tissue samples collected at 
two different time points—30 and 90 min after sPLA2 administration. Figure 2A 
shows that the amount of COX2 present in swollen tissue after a 5 μg/site Cdt sPLA2 
injection was 18.7 ± 1.23 ng/mL (n = 5), compared to values resulting from saline 
injection that were close to zero. In Figure 2B, quantification of PGE2 in the blood 
of animals collected after Cdt sPLA2 injection (5 μg/site) reveals a concentration of 
783 ± 32.4 pg./mL (n = 5), while the saline treatment resulted in 65 ± 18.6 pg./mL 
(n = 5). Thus, the amount of PGE2 was 12-fold higher than the control values. MDA, 
produced during lipid peroxidation, is widely used for determining oxidative stress, 
and the results (shown in Figure 2C) indicate that the amount of MDA in plasma was 
17.82 ± 8.65 nmol, whereas the amount of MDA released after the saline injection was 
0.58 ± 0.22 nmol (n = 5). The results presented in Figure 2A–C were obtained before 
the edema peak, and they show that COX2, PGE2, and MDA levels were extremely 
high in comparison with the control. However, the samples from the material col-
lected at 90 min or after the peak of edema showed that the COX2, PGE2, and MDA 
levels did not significantly vary from the control (saline), as shown in Figure 2D–F.
4.  Edema induced by sPLA2 from Crotalus durissus terrificus involves 
PLC and PKC signaling
The metabolism of AA is a crucial point in the course of proinflammatory 
secretory phospholipase A2 (sPLA2). These enzymes basically have two distinct 
molecular domains, one involved in catalysis and the other responsible for receptor 
interaction, which allows sPLA2 to mobilize other enzymes involved in the produc-
tion of proinflammatory mediators. In addition, studies indicate that sPLA2 recep-
tors can mediate their activity through G-protein, and therefore, they can trigger 
the activation of phospholipase C (PLC), activating the phosphokinase C (PKC) 
signaling pathway and leading to potentialization of cytoplasmic PLA2 (cPLA2) and 
COX2. In Figure 2A, we show the effect of the different treatments  
on edema induced by sPLA2 of Crotalus durissus terrificus (Cdt sPLA2). In Figure 2A,  
the results clearly show that the edema peak induced by sPLA2 produces an increase 
of 0.278 ± 0.016 mL (5 μg/site; n = 5). About 20 μL of PKC inhibitor (GF109203X; 
Tocris 30 mg/kg, dissolved in 0.5% DMSO) was injected by endovenous route 
30 min (n = 5) before administering sPLA2. The PKC inhibitor was able to sig-
nificantly reduce edema induced by sPLA2, which was 0.123 ± 0.018 mL (n = 5). 
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About 20 μL of PLC inhibitor (U73122; Tocris; 30 mg/kg, dissolved in 0.5% DMSO) 
was injected intravenously 30 min prior to application of sPLA2, revealing that 
the peak of edema was 0.167 ± 0.021 mL (n = 5), which was significantly lower 
than the edema peak induced by sPLA2. In Figure 2B, we show the effect of the 
specific inhibitor against cPLA2 and COX2. To assess the effect of arachidonyl 
trifluoromethyl ketone (AACOCF3) (Sigma-Aldrich, 30 mg/kg, dissolved in 0.5% 
DMSO), each animal received 20 μL of the compound by endovenous route 30 min 
(n = 5) before injecting sPLA2; there was a significant decrease in the edema, 
revealing a maximum edema of 0.218 ± 0.018 mL (n = 5). About 20 μL of N-[2-
(cyclohexyloxy)-4-nitrophenyl]methanesulfonamide (NS-398) (Cayman Chemical, 
30 mg/kg, dissolved in 0.5% DMSO) was injected intravenously 30 min prior to 
application of sPLA2, and the peak of the resulting edema was 0.146 ± 0.021 mL 
(n = 5), which is also significantly lower than the edema peak induced by sPLA2.
The Figures 1 and 2 show that sPLA2 triggers proinflammatory activity by a 
signaling pathway involving PKC and PLC. In the case of PLC, two products are 
generated, diacylglycerol (DAG) and inositol triphosphate (IP3), which can induce 
Figure 3. 
Values of edema induced by sPLA2 of Cdt at the adjusted concentration of 10 μg/site (n = 5). (A) The effect of 
the inhibitor of PKC (PKC inhibitor 30′) and inhibitor of PLC (PLC inhibitor 30′). In (B), we evaluated the 
edema induced by sPLA2 in the presence of a specific inhibitor of cPLA2 (AACOCF3) and inhibitor of COX2 
(NS-398).
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the phosphorylation of several proteins [14, 39–43]. Thus, the sPLA2 of Crotalus 
durissus terrificus venom may induce an increase in AA metabolism through the 
interaction of Cdt sPLA2 with G-protein coupled cellular receptors, which activate 
PLC, generating PUFAs and AA. Figures 2 and 3 present evidence of intercon-
nections and pathways that generate AA, PLC, and PKC, with cPLA2 and COX2 
revealing a possible route of signaling and mobilization of AA, and which could 
include PUFA release from membrane phospholipids. Figure 2 also shows that the 
edema induced by sPLA2 involves the presence of ROS and lipid peroxidation, and 
that the AA produced can be oxidized to generate MDA as one of the byproducts 
[39, 44–46]. The results shown in Figures 2 and 3 suggest that increased cellular 
oxidative stress and AA mobilization happen intensely and quickly. In this work, we 
have shown a possible mechanism of edema action induced by sPLA2 from Crotalus 
durissus terrificus, suggesting that the enzymatic activity of Cdt sPLA2 may partici-
pate in the inflammatory process, but this activity could also involve the presence of 
cellular receptors. sPLA2 induces two mechanisms. One mechanism increases oxi-
dative stress, especially in the form of hydrogen peroxide, which leads to increased 
MDA concentrations; thus, increased oxidative stress has a relevant role in the 
course of edema. On the other hand, edema induced by sPLA2 also involves a PLC 
signaling pathway, which mobilizes IP3 (and intracellular calcium) and DAG. These 
two compounds potentiate the PKC signaling pathway and can lead to a significant 
increase of cPLA2 through cPLA2 phosphorylation, and this results in enhanced 
AA metabolism via COX2, an enzyme that could be a second important point in the 
control of induced inflammation by sPLA2 from Crotalus durissus terrificus.
5.  “To be or not to be” enzymatically active important for Cdt sPLA2 
inflammation
A great question that arises for characterizing the pharmacological and biological 
activity of Cdt sPLA2 is the importance of the enzymatic activity of sPLA2. For many 
years, several studies concluded that all biological, physiological, pharmacological, 
and pathological activity depended on the enzymatic activity of sPLA2, and this 
remained unanimous until the 1990s. In 1984, the structure and function of the 
basic sPLA2 of Agkistrodon piscivorus were elucidated, leading to the first structural 
characterization of basic Lys49 sPLA2 [47]. This enzyme also exhibits a moderate 
enzymatic activity on membrane phospholipids [47]. Subsequently, several works 
with purified Lys49 basic sPLA2 from snake (Bothrops sp.) were able to induce several 
pharmacological activities, such as pronounced edema, myonecrosis, oxidative stress, 
nephrotoxicity, insulin degranulation, and anticoagulant activity [17, 48–52]. In the 
case of the sPLA2 from Cdt, it was observed that its enzymatic activity can be practi-
cally abolished through treatment with certain compounds. Numerous natural com-
pounds have the potential to downregulate or modulate the PLA2 activities, as well as 
other enzymes involved in AA metabolism, including cPLA2 or enzymes involved in 
prostaglandin metabolization [52–56]. One of the most abundant polyphenols in the 
human diet, 5-caffeoylquinic acid (5CQA), exerts potent anti-inflammatory, anti-
bacterial, and antioxidant activities. The anti-inflammatory activity of 5CQA may 
involve multiple mechanisms of action, including the inhibition of the production 
and secretion of chemical mediators involved in the inflammatory process.
In Figure 3A, we show the effect of 5CQA on edema induced by purified sPLA2 
from Cdt. When incubated with sPLA2, 5CQA forms a stable molecular complex 
and may interact with the catalytic site of the protein and strongly decrease its 
enzymatic activity, changing the secondary structure and leading to the virtual 
abolishment of sPLA2 enzymatic activity. The edematogenic assay performed with 
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native sPLA2 and 5CQA incubated with sPLA2 clearly showed that edema induced 
by sPLA2:5CQA was not abolished, but significantly diminished (Figure 4A). Thus, 
in part, the anti-inflammatory effect of 5CQA probably involves the downregula-
tion of pharmacological and enzymatic activity of sPLA2 [57, 58]. In Figure 3B,  
we show the effect of p-bromophenacyl bromide (p-BPB) and umbelliferone 
(7-HOC) on edema induced by sPLA2. These data reveal that previous treatment 
with sPLA2/7-HOC highly decreased the proinflammatory effect induced by sPLA2 
purified from Cdt, whereas previous treatment with p-BPB abolished this effect.
Unlike flavonoids, both compounds 7-HOC and p-BPB chemically react with 
the structure of sPLA2 and form highly stable molecular complexes, both inducing 
large structural modifications that lead to the virtual abolishment of the enzymatic 
activity of sPLA2. However, the edematogenic experiments conducted with both 
compounds incubated with sPLA2 did not abolish the proinflammatory effect 
induced by the protein, as shown in Figure 3B. Thus, in this case, comparison 
between the results from pharmacological assays suggests that the abolishment of 
enzymatic activity did not suppress or inhibit the pharmacological effect of sPLA2. 
This paradox between enzymatic activity and pharmacological effect suggests that 
at least one more complex pharmacological mechanism is involved in the enzymatic 
activity, which is independent of the enzymatic activity only. These facts suggest 
the existence of a distinct pharmacological site, as already proposed by [10, 20].
Figure 4. 
In (A), we show paw edema induced after the injection of sPLA2 and sPLA2:5CQA (10 μg/paw) into the 
right paw of Swiss mice. Measurements were performed after 30, 60, 120, 180, and 240 min, and statistical 
differences were observed with sPLA2 incubated with 5CQA. In (B), we show enzymatic activity analyzed 
using 4N3OBA as a substrate, then monitored at a wavelength of 425 nm. In this condition, we examined the 
effect of the substrate on the enzymatic activity of the native and 5CQA-pretreated sPLA2 (sPLA2:5CQA). 
Chemical treatment of sPLA2 with 5CQA shifts both the Km and Vmax of the native sPLA2. In (C), we show 
the mouse paw edema induced by untreated sPLA2 and sPLA2 treated with umbelliferone (sPLA2:7-HOC) or 
with p-bromophenacyl bromide (sPLA2:p-BPB). Doses of 10 μg/paw were used. Observations were conducted 
at intervals of 30, 60, 90, 120, and 180 min. (D) Results of enzymatic kinetic analysis of untreated (sPLA2) 
and 7-HOC- or p-BPB-treated sPLA2 (sPLAs:7-HOC) using 4N3OBA as substrate. sPLA2 Vmax; sPLA2:7-
HOC Vmax. For the enzymatic assay results in (B) and (D), each point represents the mean ± SEM of n = 12 
and *p < 0.05, and in (A) and (C), each point represents the mean ± SEM of five experiments and *p < 0.05.
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The authors performed several mutagenesis experiments besides those analyzing 
its catalytic site; there is another pharmacological site located in the calcium bind-
ing loop, and the presence of a second pharmacological site has also been consid-
ered by [8, 59, 60]. Thus, the enzymatic activity of sPLA2 from Cdt is not crucial for 
its pharmacological effect and involves other molecular regions, which are col-
lectively designated as pharmacological sites [51, 61]. Some studies performed with 
sPLA2 from Crotalus durissus ssp. showed that the calcium binding loop is involved 
in the pharmacological activity [57], and others performed by [52] showed that 
regions close to the active site of sPLA2 could also be involved. According to [54], 
the C-terminal region could also participate in the interaction with pharmacologi-
cal receptors. Even so, the crucial and commonly raised point is that the decreased 
enzymatic activity of Cdt sPLA2 is not accompanied by a proportional decrease in 
the proinflammatory activity of this enzymatic toxin, as shown by treatment of Cdt 
sPLA2 with p-BPB (Figure 4).
6.  Analysis of peroxiredoxins during edema induced by sPLA2 from 
Crotalus durissus terrificus
Oxidative stress is implicated in numerous proinflammatory responses in mam-
malian cells. H2O2 is known to trigger the release and metabolism of AA in various 
cell types, but the mechanisms involved appear to diverge profoundly from one cell 
to another. Thus, mobilization of AA in response to oxidative stress appears to be a 
very complex process involving potentially multiple enzymes and pathways. Studies 
reveal that the pathological actions induced by sPLA2 from snake venom involve 
the induction of significant increases in proinflammatory mediators that may also 
induce a significant rise in reactive oxygen species levels, which can effectively 
lead to the establishment of numerous events. Thus, the decrease or control of the 
concentration of these reactive oxygen species may contribute to the decrease of 
several pathological actions induced by the A2 secretory phospholipase venom. This 
is evidenced in some studies, such as those that used plant extracts with antioxidant 
action. The increase in the cellular oxidative process resulting from the mobiliza-
tion of AA is, in short, associated with the mobilization of H2O2 [62–64]; however, 
this event is not known to be the case for the sPLA2 found in several snake venoms. 
Some studies show that there is a direct cause and effect relationship between 
the increased expression of several calcium-dependent PLA2 isoforms and the 
increased concentration of hydrogen peroxide. Besides, this mechanism involves 
the presence of G-protein-bound cellular receptors and the consequent protein 
kinase activation. In addition, much data support the possible existence of cross talk 
between cPLA2 and sPLA2 while eliciting a full AA release response [63, 65, 66]. 
During the action of secretory and cytosolic A2 phospholipases, a large amount of 
AA is produced, which can be considered one of the major components that may be 
reduced via enzymatic peroxidation to prostaglandins, leukotrienes, thromboxanes, 
and other cyclooxygenase-, lipoxygenase-, or cytochrome P-450-derived products. 
Thus, during the process of oxidative stress, AA and other bioactive lipids can be 
converted into lipid hydroperoxide (LOOH). LOOHs are the primary products of 
lipid peroxidation, which are relatively stable and long lasting compared to other 
ROS. Among the many different aldehydes, which can be formed as secondary prod-
ucts during lipid peroxidation, MDA appears to be the most mutagenic [36, 56, 67].
The most accepted paradigm is that oxidative stress initiates a chain reaction of 
lipid peroxidation, which can be reduced by the presence of tocopherol  
(e.g., vitamin E) or some other chain-breaking antioxidant. However, several 
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studies have shown that these antioxidants do not neutralize the oxidized phos-
pholipids that were formed prior to the application of these compounds. Thus, 
lipid peroxidation is not spontaneously reversible, and enzymatic pathways that 
return lipids to their reduced states have been described. On the other hand, several 
authors showed that peroxiredoxins (Prxs), particularly Prx 6, play an essential 
role in the reduction of H2O2 and short hydroperoxides; besides, they can directly 
reduce phospholipid hydroperoxides. Prxs are thiol-dependent peroxidases that 
catalyze the reduction of a wide variety of hydroperoxides, and the catalytic activity 
is provided by the presence of a highly conserved catalytic cysteine residue, whose 
oxidation by hydroperoxide generates sulfenic acid (Cys-SOH). The Prx reduction 
mechanism involving Cys-SOH is a matter of debate, with glutaredoxin 2 (GRX2), 
thioredoxin 3 (Trx3), thioredoxin reductase 2 (Trr2), and ascorbate being proposed 
as possible reducers [68–70]. Several other studies revealed that, during oxidative 
stress, several Prxs are overexpressed, which can be used as a sensor of oxidative 
stress in several cells [71–73]. Thus, Prxs represent a group of antioxidant proteins 
able to decompose several types of hydroperoxides at rates of 105–8 M/second. These 
enzymes utilize a cysteine residue, which, after the peroxide decomposition, oxi-
dizes (CP-SOH), forming a disulfide bond with a second cysteine, which is reduced 
by the enzymes thioredoxin (Trx) and thioredoxin reductase (TrxR). In addition, 
several drugs have been characterized as peroxiredoxin inhibitors, and their use 
has been helpful in unraveling the physiological and biological roles of certain 
peroxiredoxins. Among these Prx inhibitors, the best known is adenanthin (Adn), 
which inhibits Prxs I, Prx II, and other thiol-dependent antioxidant enzymes [74, 
75]. Another commercial drug is MJ33, which is described as a potent inhibitor of 
Prx 6, an extremely essential enzyme for regulating oxidative stress, inflammation, 
and NADPH oxidase (NOX)2 activation [76]. In addition, conoidin A (ConA) is 
characterized as a potent inhibitor of peroxiredoxin II, an antioxidant enzyme that 
acts in the intracellular signaling and defense against oxidative stress [77]. Enzyme 
inhibition is one of the ways in which enzyme activity is regulated experimentally 
and naturally.
In the case of the pharmacological tests, inoculation of 5 μg sPLA2 purified from 
the total venom of Crotalus durissus terrificus induced an inflammatory reaction, 
revealing a typical acute edema with a peak at 60 min (Figure 5). To assess the 
effects of inhibitors, MJ33, ConA, and Adn were injected intraperitoneally (2 μg/g 
mice) 30 min prior to administration of PLA2 isolated from Cdt venom. As shown 
in Figure 5A, MJ33 showed insignificant anti-inflammatory activity that was only 
observed along with the edema peak. Figure 5B shows the effect of ConA admin-
istrated before sPLA2, revealing insignificant inhibition of edema. Although both 
MJ33 and ConA are essential Prx inhibitors, they display some limitations, as found 
with MJ33, which is a specific inhibitor of Prx 6. Prx 6 is a complex Prx, exhibiting 
its maximal antioxidant activity only at acidic pH values [78].
Prx 6 shows calcium-independent phospholipase A2 enzyme activity that is 
also maximal at acidic pH [79]. The determination of its functional and enzymatic 
properties was recently elucidated. The low MJ33 inhibitory effect observed in our 
study could have been due to the presence of a calcium-independent PLA2 domain. 
Some studies showed that Prx 2 appear to be an essential negative regulator of 
LPS-induced inflammatory signaling through modulation of ROS synthesis via 
NADPH oxidase activities; therefore, Prx 2 is crucial for the prevention of exces-
sive host responses to microbial products [80]. Although ConA shows the ability 
to covalently inhibit Prx 2 activity, the results presented in Figure 5B suggest that 
Prx 2 does not play a relevant role in reducing edema induced by Cdt sPLA2. On 
the other hand, LPS stimulates monocytes/macrophages through Toll-like receptor 
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4 (TLR4), resulting in a series of signaling activation events, which potentiate the 
production of inflammatory mediators, such as IL-6 and TNF-α [81, 82]. The results 
presented in Figure 5C clearly show that thiol-dependent antioxidant enzymes play 
an essential role in edema control and recovery induced by sPLA2 purified from 
Figure 5. 
In (A), we show paw edema induced after the injection of sPLA2 and sPLA2:MJ33 (5 μg/paw) into the right 
paw of Swiss mice. Measurements were performed after 30, 60, 120, 180, 240 and 480 min, and statistical 
differences were observed with sPLA2 applied after MJ33 injection 30 minutes before sPLA2 injection. In (B), we 
show paw edema induced after the injection of sPLA2 and sPLA2:ConA (5 μg/paw) into the right paw of Swiss 
mice. Measurements were performed after 30, 60, 120, 180, 240 and 480 min, and statistical differences were 
observed with sPLA2 incubated with ConA (conoidin A) applied 30 minutes before sPLA2. In (C), we evaluate 
the effect of sPLA2 in comparison with adenanthin (Adn) previously applied 30 min before sPLA2. Each point 
represents the mean ± SEM of five experiments and *p < 0.05.
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Cdt, and, similar to ConA and MJ33, these enzymes did not exhibit an inhibition 
or decrease of the edema peaks that occur at 60 min. Figure 5C also reveals that 
the edematogenic effect induced by sPLA2 diminished after 60–90 min, and the 
hind paw volume returned to its normal volume after 240 min. However, in ani-
mals treated with Adn 30 min before the sPLA2 injection, the edematogenic effect 
persisted for even 8 h after the experiment.
7. Conclusion
During inflammation (edema), induced by purified sPLA2, arachidonic acid 
generation and its metabolization by COX2 during the edema play crucial roles 
during this pharmacological event. Arachidonic acid can be mobilized by the 
catalytic activity of sPLA2 from Crotalus durissus terrificus (or other sources) 
or by activation of cytosolic PLA2. The enzymatic activity of secretory PLA2 
(sPLA2) was not crucial for this initial mobilization, and the presence of sPLA2 
receptors plays a crucial role in the mobilization of high amounts of arachidonic 
acid (AA). The classic AA production pathway, which basically involves cPLA2 
modulation, also involves the interaction of a more complex pathway that includes 
the activation of PLC, producing IP3 and DAG. In turn, IP3 and DAG activate 
PKC, stimulating a strong increase of AA by cPLA2 [1, 83, 84]. However, AA 
is also mobilized by two other distinct pathways. One involves PLC activation, 
which has an essential role in AA production by DAG lipase and MAG lipase. In 
this pathway, catalysis leads to diacylglycerol hydrolysis, releasing a free fatty acid 
and monoacylglycerol as 2-acyl glycerol, which is converted to AA by MAG lipase 
action [85–87].
Another pathway that is initiated during AA mobilization involves the release of 
platelet aggregation factor (PAF)—another subproduct of the enzymatic hydrolysis 
of membrane phospholipids that cross through the cell membrane—and its specific 
receptor (PAF receptor or PAF-R) leads to the stimulation of PLC by G-protein [83, 
88]. Thus, it is possible that sPLA2 from snake venom, such as venom from Crotalus 
durissus terrificus, mobilizes AA by three different pathways, and AA oxidative 
metabolism is a key factor that induces increased ROS and oxidative stress during 
edema. In addition, there are several studies that show AA production is an impor-
tant way to increase the generation of hydrogen peroxide during inflammation. 
Thus, it is possible that the action of sPLA2 also increases cell oxidative stress and 
AA metabolism, culminating in the production of PGE2 and MDA [36]. All this 
occurs through the interaction of sPLA2 with its receptors to modulate the activity 
and function of cPLA2 and iPLA2, inducing a significant increase in AA metabo-
lism and COX2 expression, a fact that contributes to the production of free radicals 
(Figure 6) [45, 89–95].
Several studies have shown that arachidonic acid produced by the action of 
sPLA2 and cPLA2 can activate NADPH oxidase (NOX) enzymes and induce 
a significant increase in hydrogen peroxide, which gains entry to the intracel-
lular environment through aquaporins and has a predominant role in increasing 
cellular oxidative stress [91–96]. This would explain the importance of thiol-
dependent antioxidant enzymes playing key roles in the control of edema induced 
by Crotalus durissus terrificus sPLA2. On other side, the inflammation (edema) 
induced by sPLA2 involves the mobilization of arachidonic acid and hydrogen 
peroxide, and both are the main elements involved in the inflammatory process. 
The data compiled in this work suggest that oxidative stress is integral in the 
progression and maintenance of inflammation (edema) induced by sPLA2 from 
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Crotalus durissus terrificus. Furthermore, our results show that Crotalus duris-
sus terrificus sPLA2-induced edema is strongly regulated by thiol-dependent 
enzymes, and that adenanthin (Adn) was able to neutralize this control and the 
inflammatory process (edema).
On the other hand, several articles have reported that natural antioxidant 
compounds, such as flavonoids and related substances, when given prior to sPLA2 
injection, have significant anti-inflammatory activities. This probably stems from 
the ability of many of these compounds to partially inhibit the enzymatic and 
pharmacological activities of sPLA2 from Crotalus durissus terrificus, as well as from 
their strong antioxidant activities [53–56, 97]. Thus, the search for new natural 
compounds with anti-inflammatory properties remains an important area of 
research.
Figure 6. 
Summary of possible inflammation mechanism of Cdt sPLA2 action during the inflammatory process.
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